noting appreciation work done technology economic assessment panel medical technical options committee noting appreciation progress made since adoption decision xv parties operating paragraph article montreal protocol establishing certain date cease submitting nominations metered dose inhalers sole active ingredient salbutamol recalling paragraph decision xv relating phase out chlorofluorocarbons metered dose inhalers active ingredient solely salbutamol authorize levels production consumption necessary satisfy essential uses chlorofluorocarbons metered dose inhalers asthma chronic obstructive pulmonary disease specified annex present decision parties operating paragraph article montreal protocol licensing authorizing allocating essential use exemptions chlorofluorocarbons manufacturer shall take account pre post stocks controlled substances described paragraph decision iv one operational supply maintained manufacturer reference paragraph decision xv request parties operating paragraph article montreal protocol submit date ozone secretariat prior eighteenth meeting parties time regulation regulations determine non vast majority chlorofluorocarbons metered dose inhalers active ingredient solely salbutamol proposed annex essential use nominations chlorofluorocarbons metered dose inhalers approved seventeenth meeting parties metric tonnes party amount nominated amount approved amount nominated amount approved european community russian federation united states america